These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18200628)

  • 1. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability.
    Fasano A; Colosimo C; Miyajima H; Tonali PA; Re TJ; Bentivoglio AR
    Mov Disord; 2008 Apr; 23(5):751-5. PubMed ID: 18200628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia.
    Kono S; Suzuki H; Takahashi K; Takahashi Y; Shirakawa K; Murakawa Y; Yamaguchi S; Miyajima H
    Gastroenterology; 2006 Jul; 131(1):240-5. PubMed ID: 16831606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
    Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
    Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aceruloplasminemia].
    Miyajima H
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1290-2. PubMed ID: 11464482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.
    Hofmann WP; Welsch C; Takahashi Y; Miyajima H; Mihm U; Krick C; Zeuzem S; Sarrazin C
    Scand J Gastroenterol; 2007 Sep; 42(9):1088-94. PubMed ID: 17710675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis.
    Pérez-Aguilar F; Burguera JA; Benlloch S; Berenguer M; Rayón JM
    J Hepatol; 2005 Jun; 42(6):947-9. PubMed ID: 15885371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurological presentation of ceruloplasmin gene mutations.
    McNeill A; Pandolfo M; Kuhn J; Shang H; Miyajima H
    Eur Neurol; 2008; 60(4):200-5. PubMed ID: 18667828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of aceruloplasminemia presenting as cerebellar ataxia with homozygous mutation nt2602 delG].
    Nagata M; Takiyama Y; Shimazaki H; Nakano I; Miyajima H
    No To Shinkei; 2004 Oct; 56(10):885-9. PubMed ID: 15609677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
    Pelucchi S; Pelloni I; Arosio C; Mariani R; Piperno A
    Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate.
    Kuhn J; Bewermeyer H; Miyajima H; Takahashi Y; Kuhn KF; Hoogenraad TU
    Brain Dev; 2007 Aug; 29(7):450-3. PubMed ID: 17307325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox active iron accumulation in aceruloplasminemia.
    Gonzalez-Cuyar LF; Perry G; Miyajima H; Atwood CS; Riveros-Angel M; Lyons PF; Siedlak SL; Smith MA; Castellani RJ
    Neuropathology; 2008 Oct; 28(5):466-71. PubMed ID: 18282164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ceruloplasmin deficiency or aceruloplasminemia].
    Shimizu N
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):176-7. PubMed ID: 9645036
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of desferrioxamine in the treatment of aceruloplasminemia.
    Miyajima H; Takahashi Y; Kamata T; Shimizu H; Sakai N; Gitlin JD
    Ann Neurol; 1997 Mar; 41(3):404-7. PubMed ID: 9066364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system involvement in a rare genetic iron overload disorder.
    Bethlehem C; van Harten B; Hoogendoorn M
    Neth J Med; 2010 Oct; 68(10):316-8. PubMed ID: 21071777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload.
    Dunaief JL; Richa C; Franks EP; Schultze RL; Aleman TS; Schenck JF; Zimmerman EA; Brooks DG
    Ophthalmology; 2005 Jun; 112(6):1062-5. PubMed ID: 15882908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
    Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
    J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The copper-iron connection: hereditary aceruloplasminemia.
    Nittis T; Gitlin JD
    Semin Hematol; 2002 Oct; 39(4):282-9. PubMed ID: 12382203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus.
    Logan JI; Harveyson KB; Wisdom GB; Hughes AE; Archbold GP
    QJM; 1994 Nov; 87(11):663-70. PubMed ID: 7820540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations.
    Bosio S; De Gobbi M; Roetto A; Zecchina G; Leonardo E; Rizzetto M; Lucetti C; Petrozzi L; Bonuccelli U; Camaschella C
    Blood; 2002 Sep; 100(6):2246-8. PubMed ID: 12200392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.